Puneet Kumar Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Puneet Kumar Singh has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
- Snehasish Mishra
School of Biotechnology, Campus-11, KIIT Deemed-to-be-University, Bhubaneswar, Odisha, India
5 shared publications - Partha Bandyopadhyay2 shared publications
- Pratikhya Mohanty2 shared publications
- Ranjan Kumar Mohapatra
Department of Chemistry, Government College of Engineering, Keonjhar, Odisha, India
2 shared publications - Saroj K. Swain2 shared publications
- Saswati Mohanty2 shared publications
Latest Publications
- 31 July 2026
- Published by Elsevier
- p. 343-375
Effect of agro-waste incorporated fish feed on the growth of carnivorous fish
- 31 July 2026
- Published by Elsevier
- p. 343-375
Effect of agro-waste incorporated fish feed on the growth of carnivorous fish
- 31 July 2026
- Published by Elsevier
Contributors
- Open Access
- 9 July 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (7) , e72792
Emerging Novel SARS‐CoV‐2 Subvariants and the Advantages of AI‐ML in Deciphering the Mutation Trends, Genomic Surveillance and Vaccine Development
Background and Aim: The world witnessed COVID‐19 in 2025 yet again, a resurgence driven by LF.7 and NB.1.8.1 subvariants of JN.1. With Singapore, Hong Kong and Thailand as the epicenter this time, these variants demonstrated rapid geographic spread and temporal dominance across regions including India, the United States (US), the United Kingdom (UK), and China. Genomic surveillance highlighted a sharp peak due to JN.1, followed by rising trends due to LF.7 and NB.1.8.1. Thus, a perspective was assumed aiming to get insights into the shifting epidemiological and transmission dynamics of COVID‐19, and how recent advanced technologies like AI‐ML could play a key role in deciphering the mutation trends of the novel virus, global genomic surveillance and vaccine research and development. Methods: Literature on recent global COVID cases was sourced online using reliable dedicated search engines. The limited available data from sources was used to get insights. Data were further analyzed, primarily stressing on the molecular‐level interplay within the virus and the host, possible technological interventions to know the infectivity and predict the transmission patterns, and the role of artificial intelligence and machine learning integration as solutions for vaccine designing to strategize community health. Results: India recorded over 3900 active cases in the year 2025 till early June. Kerala and Maharashtra contributed the majority of the fresh cases. Most reported cases were clinically mild, but isolated severe outcomes were witnessed, particularly among the high‐risk subjects. Despite successful mass vaccination drives, recent transmission suggested a dynamic interplay of the waning immunity, adaptability of the subvariants, and altered public behavioral patterns. Conclusions: Integrated AI‐ML tools greatly enhanced the real‐time response and resource planning through genome surveillance, predictive modeling, and outbreak predictions. In silico cutting‐edge technologies are useful tools facilitating rapid assessment of the spread and strengthening decision‐making in public healthcare. Designing AI‐assisted strategies and continued monitoring were vital to mitigate threats of infectious diseases in the future.
- 9 July 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (7) , e72792
Open AccessEmerging Novel SARS‐CoV‐2 Subvariants and the Advantages of AI‐ML in Deciphering the Mutation Trends, Genomic Surveillance and Vaccine Development
Background and Aim: The world witnessed COVID‐19 in 2025 yet again, a resurgence driven by LF.7 and NB.1.8.1 subvariants of JN.1. With Singapore, Hong Kong and Thailand as the epicenter this time, these variants demonstrated rapid geographic spread and temporal dominance across regions including India, the United States (US), the United Kingdom (UK), and China. Genomic surveillance highlighted a sharp peak due to JN.1, followed by rising trends due to LF.7 and NB.1.8.1. Thus, a perspective was assumed aiming to get insights into the shifting epidemiological and transmission dynamics of COVID‐19, and how recent advanced technologies like AI‐ML could play a key role in deciphering the mutation trends of the novel virus, global genomic surveillance and vaccine research and development. Methods: Literature on recent global COVID cases was sourced online using reliable dedicated search engines. The limited available data from sources was used to get insights. Data were further analyzed, primarily stressing on the molecular‐level interplay within the virus and the host, possible technological interventions to know the infectivity and predict the transmission patterns, and the role of artificial intelligence and machine learning integration as solutions for vaccine designing to strategize community health. Results: India recorded over 3900 active cases in the year 2025 till early June. Kerala and Maharashtra contributed the majority of the fresh cases. Most reported cases were clinically mild, but isolated severe outcomes were witnessed, particularly among the high‐risk subjects. Despite successful mass vaccination drives, recent transmission suggested a dynamic interplay of the waning immunity, adaptability of the subvariants, and altered public behavioral patterns. Conclusions: Integrated AI‐ML tools greatly enhanced the real‐time response and resource planning through genome surveillance, predictive modeling, and outbreak predictions. In silico cutting‐edge technologies are useful tools facilitating rapid assessment of the spread and strengthening decision‐making in public healthcare. Designing AI‐assisted strategies and continued monitoring were vital to mitigate threats of infectious diseases in the future.
- Open Access
- 17 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Critical Evaluation of the Impact of COVID‐19 Pandemic on Child Health and Wellbeing and Suggested Preparedness for Future Pandemics–A Narrative Review
Background and Aims: The immediate and long‐term effects of COVID‐19 pandemic on the children go beyond just being a viral infection. A child's mental health and psychological issues like irritability, anxiety, sadness, non‐attentiveness, attention deficit and hyperactive disorder needed evaluation. Based on these study queries, an investigation was carried out to correlate the psychological state and the emergency measures in children with respect to the health and wellbeing outcomes. Methods: A web‐search across scientific databases like the Web of Science, Scopus and PubMed was undertaken for a situational review through available literature, and derive credible solutions. This narrative review included peer‐reviewed articles published between January 2020 and February 2026 in English language, focusing on children wellbeing in wake of the COVID‐19 pandemic. After analysing the authenticity and relevance of the literature, 158 articles/data were shortlisted for further analyses. The data were qualitatively validated, synthesised into discrete sections and interpreted in the context of the objective of the study. Result: Children particularly in low‐economy families were likely to experience violence and abuse if they stayed for long in high‐risk settings like refugee settlements for internally displaced community. On the contrary, the children of high‐economy families had weight gain issues owing to erratic consumption patterns of high‐calorie food (like dairy products and sugar‐rich packaged snacks) coupled with restricted or limited physical activities. Their dietary patterns and unhealthy eating habits needed monitoring and restrictions to curb obesity risk in the long run. Elevated stress, anxiety and depression levels in a child may result in cognitive impairment. The possibilities of their getting addicted, developing insomnia and acquiring non‐communicable illnesses were aspects to consider. Preventive measures like social distancing, lockdowns and shutdowns and mass vaccination drives had wider and critical long‐term impact on the young and adolescent. Formulating workable modalities to identify critical influencing factors of a pandemic and assess the impact on the children and beyond is essential for foolproof solutions to combat future occurrences. Conclusion: Identifying the associated risk factors and correlating the emergency measures and psychological health seem essential. The supply of quality food seamlessly to the affected communities and the provision of protective gears for the healthcare workers could help keep the children well‐fed and relaxed while ensuring the wellbeing of healthcare workers. Maternal and infant care, child‐health services, and life‐saving medicines and vaccines would also help ease the pressure.
- 17 March 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (3)
Open AccessCritical Evaluation of the Impact of COVID‐19 Pandemic on Child Health and Wellbeing and Suggested Preparedness for Future Pandemics–A Narrative Review
Background and Aims: The immediate and long‐term effects of COVID‐19 pandemic on the children go beyond just being a viral infection. A child's mental health and psychological issues like irritability, anxiety, sadness, non‐attentiveness, attention deficit and hyperactive disorder needed evaluation. Based on these study queries, an investigation was carried out to correlate the psychological state and the emergency measures in children with respect to the health and wellbeing outcomes. Methods: A web‐search across scientific databases like the Web of Science, Scopus and PubMed was undertaken for a situational review through available literature, and derive credible solutions. This narrative review included peer‐reviewed articles published between January 2020 and February 2026 in English language, focusing on children wellbeing in wake of the COVID‐19 pandemic. After analysing the authenticity and relevance of the literature, 158 articles/data were shortlisted for further analyses. The data were qualitatively validated, synthesised into discrete sections and interpreted in the context of the objective of the study. Result: Children particularly in low‐economy families were likely to experience violence and abuse if they stayed for long in high‐risk settings like refugee settlements for internally displaced community. On the contrary, the children of high‐economy families had weight gain issues owing to erratic consumption patterns of high‐calorie food (like dairy products and sugar‐rich packaged snacks) coupled with restricted or limited physical activities. Their dietary patterns and unhealthy eating habits needed monitoring and restrictions to curb obesity risk in the long run. Elevated stress, anxiety and depression levels in a child may result in cognitive impairment. The possibilities of their getting addicted, developing insomnia and acquiring non‐communicable illnesses were aspects to consider. Preventive measures like social distancing, lockdowns and shutdowns and mass vaccination drives had wider and critical long‐term impact on the young and adolescent. Formulating workable modalities to identify critical influencing factors of a pandemic and assess the impact on the children and beyond is essential for foolproof solutions to combat future occurrences. Conclusion: Identifying the associated risk factors and correlating the emergency measures and psychological health seem essential. The supply of quality food seamlessly to the affected communities and the provision of protective gears for the healthcare workers could help keep the children well‐fed and relaxed while ensuring the wellbeing of healthcare workers. Maternal and infant care, child‐health services, and life‐saving medicines and vaccines would also help ease the pressure.
- Open Access
Indian Biosimilars and Vaccines at Crossroads–Replicating the Success of Pharmagenerics
Background: The global pharma sector is fast shifting from generics to biologics and biosimilars with the first approval in Europe in 2006 followed by US approval in 2015. In the form of Hepatitis B vaccine, India saw its first recombinant biologics approval in 2000. Around 20% of generic medications and 62% of vaccines are now supplied by the Indian pharmaceutical industry. It is this good position in biologics and biosimilars production that could potentially improve healthcare via decreased treatment cost. India has witnessed large investments in biosimilars over the years. Numerous India-bred new players, e.g., Enzene Biosciences Ltd., are keen on biosimilars and have joined the race alongside the emerging giants, e.g., Biocon and Dr. Reddy’s. A very positive sign was the remarkable disposition during the COVID-19 pandemic by Bharat Biotech and the Serum Institute of India. India’s biopharmaceutical industry has been instrumental in producing and supplying preventives and therapeutics to fight COVID-19. Despite a weak supply chain and workforce pressure, the production was augmented to provide reasonably priced high-quality medications to more than 133 nations. Biosimilars could cost-effectively treat chronic diseases involving expensive conventional therapies, including diabetes, respiratory ailments, cancer, and connective tissue diseases. Biologics and biosimilars have been and are being tested to treat and manage COVID-19 symptoms characterized by inflammation and respiratory distress. Purpose of review: Although India boasts many universities, research centers, and a relatively skilled workforce, its global University–Industry collaboration ranking is 24, IPR ranking remains 47 and innovation ranking 39. This reveals a wide industry-academia gap to bridge. There are gaps in effective translational research in India that must be promptly and appropriately addressed. Innovation demands strong and effective collaborations among universities, techno-incubators, and industries. Methodology: Many successful research findings in academia do not get translation opportunities supposedly due to low industrial collaboration, low IP knowledge, and publication pressure with stringent timelines. In light of this, a detailed review of literature, including policy papers, government initiatives, and corporate reviews, was carried out, and the compilation and synthesis of the secondary data were meticulously summarized for the easy comprehension of the facts and roadmap ahead. For easy comprehension, charts, figures, and compiled tables are presented. Results: This review assesses India’s situation in the biosimilar space, the gaps and areas to improve for Indian investment strategies, development, and innovation, addressing need for a more skilled workforce, industrial collaboration, and business models. Conclusions: This review also proposes forward an approach to empowering technopreneurs to develop MSMEs for large-scale operations to support India in taking innovative thoughts to the global level to ultimately realize a self-reliant India. The limitations of the compilation are also highlighted towards the end.
Open AccessIndian Biosimilars and Vaccines at Crossroads–Replicating the Success of Pharmagenerics
Background: The global pharma sector is fast shifting from generics to biologics and biosimilars with the first approval in Europe in 2006 followed by US approval in 2015. In the form of Hepatitis B vaccine, India saw its first recombinant biologics approval in 2000. Around 20% of generic medications and 62% of vaccines are now supplied by the Indian pharmaceutical industry. It is this good position in biologics and biosimilars production that could potentially improve healthcare via decreased treatment cost. India has witnessed large investments in biosimilars over the years. Numerous India-bred new players, e.g., Enzene Biosciences Ltd., are keen on biosimilars and have joined the race alongside the emerging giants, e.g., Biocon and Dr. Reddy’s. A very positive sign was the remarkable disposition during the COVID-19 pandemic by Bharat Biotech and the Serum Institute of India. India’s biopharmaceutical industry has been instrumental in producing and supplying preventives and therapeutics to fight COVID-19. Despite a weak supply chain and workforce pressure, the production was augmented to provide reasonably priced high-quality medications to more than 133 nations. Biosimilars could cost-effectively treat chronic diseases involving expensive conventional therapies, including diabetes, respiratory ailments, cancer, and connective tissue diseases. Biologics and biosimilars have been and are being tested to treat and manage COVID-19 symptoms characterized by inflammation and respiratory distress. Purpose of review: Although India boasts many universities, research centers, and a relatively skilled workforce, its global University–Industry collaboration ranking is 24, IPR ranking remains 47 and innovation ranking 39. This reveals a wide industry-academia gap to bridge. There are gaps in effective translational research in India that must be promptly and appropriately addressed. Innovation demands strong and effective collaborations among universities, techno-incubators, and industries. Methodology: Many successful research findings in academia do not get translation opportunities supposedly due to low industrial collaboration, low IP knowledge, and publication pressure with stringent timelines. In light of this, a detailed review of literature, including policy papers, government initiatives, and corporate reviews, was carried out, and the compilation and synthesis of the secondary data were meticulously summarized for the easy comprehension of the facts and roadmap ahead. For easy comprehension, charts, figures, and compiled tables are presented. Results: This review assesses India’s situation in the biosimilar space, the gaps and areas to improve for Indian investment strategies, development, and innovation, addressing need for a more skilled workforce, industrial collaboration, and business models. Conclusions: This review also proposes forward an approach to empowering technopreneurs to develop MSMEs for large-scale operations to support India in taking innovative thoughts to the global level to ultimately realize a self-reliant India. The limitations of the compilation are also highlighted towards the end.
- 14 October 2022
- Published by Springer Nature in Gesunde Pflanzen
- Vol. 75 (4) , 801-814
Productivity and Profitability of Irrigated Bread Wheat (Triticum aestivum L.) are Influenced by Irrigation Scheduling and Weed Management Approaches
- 14 October 2022
- Published by Springer Nature in Gesunde Pflanzen
- Vol. 75 (4) , 801-814
Productivity and Profitability of Irrigated Bread Wheat (Triticum aestivum L.) are Influenced by Irrigation Scheduling and Weed Management Approaches